ALA-10
| Clinical data | |
|---|---|
| Other names | ALA10; 1-Acetyl-LAE; 1A-LAE; 1-Acetyl-LAE-32; 1A-LAE-32; 1-Acetyllysergic acid ethylamide; 1-Acetyl-N-ethyllysergamide; 1-Acetyl-N-ethyl-6-methyl-9,10-didehydroergoline-8β-carboxamide |
| Routes of administration | Oral |
| Drug class | Serotonin receptor modulator; Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C20H23N3O2 |
| Molar mass | 337.423 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
ALA-10, also known as 1-acetyl-LAE (1A-LAE), is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is the 1-acetyl derivative of LAE-32. 1-Acetylated lysergamides like ALD-52 (1-acetyl-LSD; 1A-LSD) are thought to function as prodrugs via deacetylation to the 1-unsubstituted analogues, which in the case of ALD-52 is LSD.